<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04929002</url>
  </required_header>
  <id_info>
    <org_study_id>7TMRS in GSD</org_study_id>
    <nct_id>NCT04929002</nct_id>
  </id_info>
  <brief_title>Carbon-13 Magnetic Resonance Spectroscopy in Glycogen Storage Diseases</brief_title>
  <official_title>Using Carbon-13 Magnetic Resonance Spectroscopy to Assess Whether High Glycogen Levels in Skeletal Muscle of Patients With Glycogen Storage Diseases is a Prelude for Muscle Damage.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Danish Research Center for Magnetic Resonance</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The project will use carbon-13 magnetic resonance spectroscopy to assess whether high&#xD;
      glycogen levels in skeletal muscle of patients with Glycogen Storage Diseases is a prelude&#xD;
      for muscle damage.&#xD;
&#xD;
      Patients with Glycogen Storage Diseases will be examined using carbon-13 MR-spectroscopy to&#xD;
      quantify the glycogen levels in lumbar, thigh and calf-muscles. The pattern of glycogen&#xD;
      concentration will be compared to the pattern of muscle atrophy found in the literature.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 2021</start_date>
  <completion_date type="Anticipated">May 2024</completion_date>
  <primary_completion_date type="Anticipated">May 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Glycogen concentration</measure>
    <time_frame>Day 1</time_frame>
    <description>The difference in muscle glycogen between patients and controls&#xD;
The difference in muscle glycogen between different muscle groups in patients.</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Glycogen Storage Disease</condition>
  <condition>McArdle Disease</condition>
  <condition>Pompe Disease (Late-onset)</condition>
  <arm_group>
    <arm_group_label>McArdle Disease</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Pompe disease</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention</intervention_name>
    <description>No intervention</description>
    <arm_group_label>Controls</arm_group_label>
    <arm_group_label>McArdle Disease</arm_group_label>
    <arm_group_label>Pompe disease</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with Pompe or McArdle disease and healthy controls&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subjects with genetically verified neuromuscular disease or healthy control&#xD;
&#xD;
          -  Healthy controls needs to be healthy to be included, evaluated by the investigator&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Ferrous objects in or around the body&#xD;
&#xD;
          -  Pacemaker or other implanted electronic devices&#xD;
&#xD;
          -  Claustrophobia&#xD;
&#xD;
          -  Inability to understand the purpose of the trial or corporate for the conduction of&#xD;
             the experiments.&#xD;
&#xD;
          -  Participation in other trials that may interfere with the results.&#xD;
&#xD;
          -  Competing conditions at risk of compromising the results of the study, evaluated by&#xD;
             the investigator.&#xD;
&#xD;
          -  Strenuous exercise in the preceding 2 days before examination&#xD;
&#xD;
          -  Pregnancy or breastfeeding&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>June 3, 2021</study_first_submitted>
  <study_first_submitted_qc>June 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 18, 2021</study_first_posted>
  <last_update_submitted>September 15, 2021</last_update_submitted>
  <last_update_submitted_qc>September 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rigshospitalet, Denmark</investigator_affiliation>
    <investigator_full_name>Mads Peter Godtfeldt Stemmerik</investigator_full_name>
    <investigator_title>PhD-student, MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glycogen Storage Disease Type II</mesh_term>
    <mesh_term>Glycogen Storage Disease</mesh_term>
    <mesh_term>Glycogen Storage Disease Type V</mesh_term>
    <mesh_term>Metabolic Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

